Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting.

The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat).

Belloso A, Saravanan K, de Carpentier J

Department of Otolaryngology-Head and Neck Surgery, Lancashire Teaching Hospitals NHS Trust, Royal Preston Hospital, Preston, United Kingdom. a.belloso@btinternet.com

We describe two innovative ideas in the treatment of iatrogenic chyle leak. The first is the early use of a pancreatic lipase inhibitor (Orlistat) to reduce fat absorption and chyle production, with consequent faster fistula healing. The second is the treatment of these patients at home in the community by district nurses backed by the hospital staff. This domiciliary approach has a positive psychological effect on the patient, permits the patient to take responsibility for their treatment, and reduces hospital length of stay minimising patient exposure to nosocomial infections.

Published 3 October 2006 in Laryngoscope, 116(10): 1934-5.
Full-text of this article is available online (may require subscription).

© 2004-2008 Xenical Research Today. All Rights Reserved.